Agios Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	89.13	76.25	88.21	139.26	203.13
Short-Term Investments	765.3	817.46	688.72	643.86	816.89
Cash & Short-Term Investments	854.43	893.71	776.93	783.12	1,020
Cash Growth	-4.40%	15.03%	-0.79%	-23.23%	78.04%
Accounts Receivable	10.58	4.11	2.81	2.21	-
Other Receivables	0.2	-	1.1	0.3	7.28
Receivables	10.78	4.11	3.91	2.51	7.28
Inventory	32.92	27.62	19.08	8.49	-
Prepaid Expenses	43.93	40.17	33.92	38.66	36.94
Total Current Assets	942.05	965.6	833.84	832.77	1,064
Property, Plant & Equipment	41.23	54.55	69.79	88.12	104.23
Long-Term Investments	310.01	638.32	29.44	313.87	266.38
Other Long-Term Assets	3.93	4.72	4.06	3.96	2.9
Total Assets	1,297	1,663	937.12	1,239	1,438
Accounts Payable	18.36	16.64	9.78	18.62	16.7
Accrued Expenses	45.46	46.86	43.17	30.35	31.97
Current Portion of Leases	18.39	16.78	15.01	13.66	11.16
Current Income Taxes Payable	-	0.87	-	-	-
Total Current Liabilities	82.21	81.16	67.96	62.63	59.83
Long-Term Leases	21.82	40.21	56.99	72	85.94
Other Long-Term Liabilities	0.09	0.88	1.16	3.28	-
Total Liabilities	104.11	122.24	126.1	137.9	145.76
Common Stock	0.08	0.07	0.07	0.07	0.07
Additional Paid-In Capital	2,555	2,494	2,437	2,386	2,334
Retained Earnings	-561.71	-148.92	-822.65	-470.56	-238.76
Treasury Stock	-802.49	-802.49	-802.49	-802.49	-802.49
Comprehensive Income & Other	2.19	-1.52	-0.44	-12.54	-1.2
Shareholders' Equity	1,193	1,541	811.02	1,101	1,292
Total Liabilities & Equity	1,297	1,663	937.12	1,239	1,438
Total Debt	40.21	56.99	72	85.66	97.09
Net Cash (Debt)	1,124	1,475	734.37	1,011	1,189
Net Cash Growth	-23.78%	100.86%	-27.39%	-14.96%	110.37%
Net Cash Per Share	19.39	25.48	13.20	18.46	19.67
Filing Date Shares Outstanding	58.59	57.3	56.19	55.29	54.64
Total Common Shares Outstanding	58.45	57.16	55.95	55.04	54.33
Working Capital	859.85	884.44	765.88	770.14	1,004
Book Value Per Share	20.41	26.96	14.50	20.00	23.78
Tangible Book Value	1,193	1,541	811.02	1,101	1,292
Tangible Book Value Per Share	20.41	26.96	14.50	20.00	23.78
Machinery	30.62	29.76	29.73	35.12	33.8
Construction In Progress	2.75	0.9	0.61	0.66	7.37
Leasehold Improvements	37.52	37.52	37.28	37.28	32.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.